The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.

source https://www.cnn.com/2019/12/23/health/new-migraine-drug-fda-approval/index.html